Company profile: Toxikon
1.1 - Company Overview
Company description
- Provider of preclinical contract research services delivering medical device product development from concept to final product, including biocompatibility testing, microbiology and reusability validation, analytical chemistry, efficacy and surgical services, and consulting and risk assessment for regulatory compliance and market approval.
Products and services
- Biocompatibility: Engineers testing to ensure device materials and manufacturing processes are biologically compatible and meet regulatory requirements, addressing material interactions and manufacturing residues
- Regulatory-focused
- Microbiology and Reusability Validation: Conducts sterility assessments, reusability validation, and microbial contamination risk evaluation to confirm device sterility and safe reuse
- Preclinical-grade
- Preclinical Medical Device Development: Architects the initial development stage with specialized tests to ensure device safety and regulatory compliance from concept to final product
- Laboratory-grade
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Toxikon
Northeast Biolab
HQ: United States
Website
- Description: Provider of GLP and clinical bioanalysis services with 15+ years of experience, offering method development, validation and transfer; LC-MS bioanalysis; pharmacokinetics sample analysis and toxicokinetic safety testing; and assay platforms including ELISA, MSD, qPCR/ddPCR, Western Blot and In Cell Western for drug testing and biomarker analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Northeast Biolab company profile →
Invivyd
HQ: United States
Website
- Description: Provider of antibody-based therapies to protect vulnerable people from serious viral infectious diseases. Offers PEMGARDA, authorized for emergency use as pre-exposure prophylaxis against COVID-19 in certain adults and adolescents; the INVYMAB platform combining viral surveillance, predictive modeling, and antibody engineering; a pipeline of COVID-19 and influenza monoclonal antibody candidates; and clinical trials, including the CANOPY Phase 3 trial.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Invivyd company profile →
Pharmaceutics International
HQ: United States
Website
- Description: Provider of science-driven contract development and manufacturing services, offering formulation development and clinical trial manufacturing for drugs and biologics; solubility/bioavailability enhancement; lyophilization formulation and cycle development with GMP scale-up; fill-finish development and aseptic fill-finish for vials, syringes, and cartridges; and ready-to-use 3mL cartridges for consistent delivery of high-viscosity, high concentration injectables.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharmaceutics International company profile →
Sanovel
HQ: Turkey
Website
- Description: Provider of pharmaceutical products, manufacturing anti-inflammatory, anti-asthmatic, and antibacterial medications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sanovel company profile →
hVIVO
HQ: Ireland
Website
- Description: Provider of niche CRO pharmaceutical services specializing in human challenge clinical trials to test vaccines and antivirals for infectious and respiratory diseases, operating Europe’s only 24-bedroom quarantine clinic with onsite virology. Offers clinical trial design and execution, lab assays, and tech-enabled volunteer recruitment (including FluCamp), alongside ESG initiatives.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full hVIVO company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Toxikon
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Toxikon
2.2 - Growth funds investing in similar companies to Toxikon
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Toxikon
4.2 - Public trading comparable groups for Toxikon
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →